Q32 Bio Inc. (NASDAQ:QTTB) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James Flynn Other companies: Lite Strategy, Inc. (Director · Since at least Oct 31, 2023); Nuvalent, Inc. (Director · Since at least Jul 28, 2021); Larimar Therapeutics, Inc. (Director · Since at least May 28, 2020); Synlogic Inc (Director · Mar 19, 2024 – Apr 26, 2025 · Past); BiomX Inc. (Director · Mar 15, 2024 – Apr 21, 2025 · Past); Oruka Therapeutics, Inc. (Director · Jan 30, 2024 – Jan 30, 2024 · Past); RiceBran Technologies (Director · Jan 3, 2024 – Jan 3, 2024 · Past); CareMax Inc (Director · Nov 17, 2022 – Nov 17, 2023 · Past); ARS Pharmaceuticals, Inc. (Director · Nov 8, 2022 – Nov 8, 2022 · Past); Da32 Life Science Tech Acquisition Corp (Director · Jul 27, 2021 – Jul 28, 2023 · Past); Oncorus Inc (Director · Oct 1, 2020 – Feb 17, 2021 · Past); Acutus Medical Inc. (Director · Aug 5, 2020 – Jan 27, 2025 · Past); Deerfield Healthcare Technology Acquisitions Corp (Director · Jul 16, 2020 – Jul 21, 2020 · Past); AdaptHealth Corp. (Director · Feb 15, 2018 – Nov 8, 2019 · Past); Alpine Immune Sciences Inc (Director · Sep 12, 2016 – Sep 12, 2016 · Past); AveXis Inc (Director · Sep 3, 2015 – Feb 10, 2016 · Past) | Director · Mar 27, 2018 – Jun 6, 2019 · Past |
| Mark Iwicki Other companies: Inhibikase Therapeutics, Inc. (Chief Executive Officer - Inhibikase · Since at least Feb 14, 2025); Third Harmonic Bio Inc. (Director · Since at least Sep 14, 2022); Akero Therapeutics Inc (Director · Since at least Jun 19, 2019); Kala Bio, Inc. (Director · Since at least Jul 19, 2017); Jade Biosciences, Inc. (Director · Apr 2, 2021 – Jun 5, 2024 · Past); Pulmatrix, Inc. (Director · Mar 20, 2017 – Jan 28, 2021 · Past); Aimmune Therapeutics Inc (Director · May 25, 2016 – Oct 10, 2020 · Past) | Director · Since at least Mar 25, 2024 |
| Mary Thistle Other companies: Aktis Oncology, Inc. (Independent Director · Since at least Jan 8, 2026); Cullinan Therapeutics, Inc. (Chair of the Compensation Committee · Since at least Aug 8, 2024); Vigil Neuroscience Inc (Director · Since at least Apr 18, 2022); Entrada Therapeutics, Inc. (Industry Leader and Independent Director · Since at least Oct 28, 2021); Alaunos Therapeutics, Inc. (Director · Nov 15, 2020 – Jun 6, 2023 · Past); Dimension Therapeutics (Chief Operating Officer · Feb 1, 2017 – Nov 7, 2017 · Past) | Director · Since at least Mar 27, 2018 |
| Steven Gillis Other companies: Kardigan, Inc. (Director · Since at least Jun 22, 2026); Takeda Pharmaceutical Co. Ltd. (Director · Since at least Mar 18, 2026); Metsera, Inc. (Director · Since at least Nov 13, 2025); Codiak BioSciences Inc (Director · Oct 13, 2020 – Feb 16, 2023 · Past); VBI Vaccines Inc. (Director · Jun 14, 2019 – Jul 27, 2023 · Past); Pulmatrix, Inc. (Director · May 16, 2019 – Aug 28, 2020 · Past) | Director · Jun 6, 2019 – Jun 14, 2023 · Past |
| Alise Reicin Other companies: Immatics N.V. (Director · Since at least Mar 18, 2026); Tectonic Therapeutic, Inc. (President and CEO, Director · Since at least Jun 20, 2024); Sana Biotechnology, Inc. (Director · Since at least Feb 3, 2021); Celgene Corporation (PRES., GLOBAL CLINICAL DEV. · Nov 1, 2018 – Nov 20, 2019 · Past) | Director · Jul 11, 2019 – Jun 14, 2023 · Past |
| Isaac Manke Other companies: Rainier Acquisition Corporation (Director · Since at least Aug 26, 2026); Addex Therapeutics Ltd (Director · Since at least Mar 18, 2026); OnKure Therapeutics, Inc. (Director · Since at least Oct 4, 2024); Chardan Healthcare Acquisition 2 Corp (Director · Apr 23, 2020 – Apr 23, 2020 · Past) | Director · Since at least Mar 25, 2024 |
| Matthew R Patterson Other companies: Vor Biopharma Inc. (Director · Feb 4, 2021 – May 22, 2025 · Past); 5 01 Acquisition Corp (Director · Oct 13, 2020 – Oct 16, 2020 · Past); Audentes Therapeutics Inc (Chief Executive Officer, Director · Jul 19, 2016 – Jan 15, 2020 · Past) | Director · Mar 27, 2018 – Jun 14, 2023 · Past |
| David Grayzel Other companies: Jade Biosciences, Inc. (Director · Feb 1, 2021 – Jun 5, 2024 · Past); Surface Oncology Inc (Director · Apr 18, 2018 – Sep 8, 2023 · Past) | Director · Since at least Mar 25, 2024 |
| Lee Kalowski Other companies: Bicycle Therapeutics PLC (President and CFO · May 22, 2019 – Apr 3, 2023 · Past); Eledon Pharmaceuticals, Inc. (Chief Financial Officer · Sep 16, 2014 – Dec 15, 2015 · Past) | PRESIDENT & CHIEF FINANCIAL OFFICER · Since at least Mar 25, 2024 |
| Jason Campagna Other companies: Intercept Pharmaceuticals Inc (Chief Medical Officer · Dec 1, 2019 – Jan 22, 2021 · Past) | Chief Medical Officer · Mar 25, 2024 – Feb 24, 2025 · Past |
| Arthur Tzianabos | Until Oct 14, 2026 · Past |
| Bill Lundberg | Board Member · Nov 4, 2026 – Nov 4, 2026 · Past |
| Brendan Burns | Senior Director, Investor Relations and Corporate Communications · Since at least Nov 4, 2026 |
| Brian Kotzin | Board Member · Nov 4, 2026 – Nov 4, 2026 · Past |
| David Appugliese | Senior Vice President, Head of People · Since at least Nov 4, 2026 |
| Diyong Xu | Director · Nov 4, 2026 – Nov 4, 2026 · Past |
| Ellie Hershberger | CHIEF DEVELOPMENT OFFICER · Since at least Sep 14, 2026 |
| Jodie Morrison | Chief Executive Officer · Since at least Jul 16, 2026 |
| John P. Atkinson | Board Member · Nov 4, 2026 – Nov 4, 2026 · Past |
| José Trevejo | CHIEF MEDICAL OFFICER · Since at least Sep 30, 2026 |
| Maria Marzilli | CHIEF BUSINESS OFFICER · Since at least Nov 5, 2026 |
| Michael Holers | Board Member · Nov 4, 2026 – Nov 4, 2026 · Past |
| Michael Lee Blum | Chief Commercial Officer · Mar 2, 2022 – Feb 23, 2023 · Past |
| Peter A. Merkel | Chief of Rheumatology · Since at least Nov 5, 2026 |
| Shelia Violette | Founder and Chief Scientific Officer · Since at least Mar 25, 2024 |
| Simon Read | Board Member · Nov 4, 2026 – Nov 4, 2026 · Past |
| Siyamak Rasty | Chief Operating Officer · Mar 27, 2018 – Jul 9, 2019 · Past |